- Home
- BKYI vs EVOK Comparison
BKYI vs EVOK Comparison
Compare BKYI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- EVOK
- Stock Information
- Founded
- BKYI 1993
- EVOK 2007
- Country
- BKYI United States
- EVOK United States
- Employees
- BKYI N/A
- EVOK N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- EVOK Health Care
- Exchange
- BKYI Nasdaq
- EVOK Nasdaq
- Market Cap
- BKYI 3.8M
- EVOK 4.2M
- IPO Year
- BKYI 1997
- EVOK 2013
- Fundamental
- Price
- BKYI $0.72
- EVOK $2.15
- Analyst Decision
- BKYI
- EVOK
- Analyst Count
- BKYI 0
- EVOK 0
- Target Price
- BKYI N/A
- EVOK N/A
- AVG Volume (30 Days)
- BKYI 239.0K
- EVOK 20.9K
- Earning Date
- BKYI 06-13-2025
- EVOK 05-13-2025
- Dividend Yield
- BKYI N/A
- EVOK N/A
- EPS Growth
- BKYI N/A
- EVOK N/A
- EPS
- BKYI N/A
- EVOK N/A
- Revenue
- BKYI $6,929,571.00
- EVOK $10,249,415.00
- Revenue This Year
- BKYI $25.12
- EVOK $58.84
- Revenue Next Year
- BKYI N/A
- EVOK $58.11
- P/E Ratio
- BKYI N/A
- EVOK N/A
- Revenue Growth
- BKYI N/A
- EVOK 97.84
- 52 Week Low
- BKYI $0.52
- EVOK $1.94
- 52 Week High
- BKYI $3.68
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- BKYI 36.02
- EVOK 28.89
- Support Level
- BKYI $0.66
- EVOK $1.94
- Resistance Level
- BKYI $0.84
- EVOK $2.40
- Average True Range (ATR)
- BKYI 0.09
- EVOK 0.21
- MACD
- BKYI 0.01
- EVOK 0.04
- Stochastic Oscillator
- BKYI 45.45
- EVOK 24.14
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.